Viewing Study NCT05983250


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-01-04 @ 6:57 AM
Study NCT ID: NCT05983250
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2023-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Sponsor: Tenax Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TNX-103-06
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View